These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 25750308)
1. AKT/mTOR down-regulation by CX-4945, a CK2 inhibitor, promotes apoptosis in chemorefractory non-small cell lung cancer cells. So KS; Rho JK; Choi YJ; Kim SY; Choi CM; Chun YJ; Lee JC Anticancer Res; 2015 Mar; 35(3):1537-42. PubMed ID: 25750308 [TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells. Bliesath J; Huser N; Omori M; Bunag D; Proffitt C; Streiner N; Ho C; Siddiqui-Jain A; O'Brien SE; Lim JK; Ryckman DM; Anderes K; Rice WG; Drygin D Cancer Lett; 2012 Sep; 322(1):113-8. PubMed ID: 22387988 [TBL] [Abstract][Full Text] [Related]
3. Luteoloside induces G Zhou M; Shen S; Zhao X; Gong X Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631 [TBL] [Abstract][Full Text] [Related]
4. Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M. So KS; Kim CH; Rho JK; Kim SY; Choi YJ; Song JS; Kim WS; Choi CM; Chun YJ; Lee JC PLoS One; 2014; 9(12):e114000. PubMed ID: 25486409 [TBL] [Abstract][Full Text] [Related]
5. Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines. Hwang DW; So KS; Kim SC; Park KM; Lee YJ; Kim SW; Choi CM; Rho JK; Choi YJ; Lee JC Pancreas; 2017 Apr; 46(4):575-581. PubMed ID: 28196025 [TBL] [Abstract][Full Text] [Related]
6. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization. Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938 [TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of α-Bisabolol in human non-small cell lung carcinoma cells are mediated via apoptosis induction, cell cycle arrest, inhibition of cell migration and invasion and upregulation of P13K/AKT signalling pathway. Wu S; Peng L; Sang H; Ping Li Q; Cheng S J BUON; 2018; 23(5):1407-1412. PubMed ID: 30570866 [TBL] [Abstract][Full Text] [Related]
8. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway. Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793 [TBL] [Abstract][Full Text] [Related]
9. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens. Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325 [TBL] [Abstract][Full Text] [Related]
10. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling. Xu X; Jiang J; Yao L; Ji B Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267 [TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894 [TBL] [Abstract][Full Text] [Related]
12. GDC-0349 inhibits non-small cell lung cancer cell growth. Yang H; Zhao J; Zhao M; Zhao L; Zhou LN; Duan Y; Li G Cell Death Dis; 2020 Nov; 11(11):951. PubMed ID: 33154352 [TBL] [Abstract][Full Text] [Related]
13. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A; Li H; Li R; Lu L; Wu X Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933 [TBL] [Abstract][Full Text] [Related]
14. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608 [TBL] [Abstract][Full Text] [Related]
15. Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma. Gong K; Miao S; Yang L; Wu Y; Guo J; Chen W; Dai J; Du J; Xi S Pharm Biol; 2020 Dec; 58(1):1044-1054. PubMed ID: 33027592 [TBL] [Abstract][Full Text] [Related]
16. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421 [TBL] [Abstract][Full Text] [Related]
18. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357 [TBL] [Abstract][Full Text] [Related]
19. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status. Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722 [TBL] [Abstract][Full Text] [Related]
20. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Li YC; He SM; He ZX; Li M; Yang Y; Pang JX; Zhang X; Chow K; Zhou Q; Duan W; Zhou ZW; Yang T; Huang GH; Liu A; Qiu JX; Liu JP; Zhou SF Cancer Lett; 2014 Mar; 344(2):239-59. PubMed ID: 24280585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]